Lavínia Maria Dal’Mas Romera

New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response

Rafael Pedro Madeira, Lavínia Maria Dal’Mas Romera, Paula Buck et al. · Journal of Immunology Research · 2021 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19

Douglas Ferreira Sales-Medina, Ludmila Rodrigues Pinto Ferreira, Lavínia Maria Dal’Mas Romera et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 19 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

TLR3 Is a Negative Regulator of Immune Responses Against Paracoccidioides brasiliensis

Grasielle Pereira Jannuzzi, José Roberto Fogaça de Almeida, Gustavo P. Amarante‐Mendes et al. · Frontiers in Cellular and Infection Microbiology · 2019 · 17 citations · Full text

Life Sciences, Immunology, Microbiology +17

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity

Caio Haddad Franco, David C. Warhurst, Tapan Bhattacharyya et al. · International Journal for Parasitology Drugs and Drug Resistance · 2020 · 14 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

The Critical Role of Notch1–TLR 4 Signaling in the Inflammatory and Fungicidal Activity of Macrophages Against Paracoccidioides brasiliensis Strain Pb18

Lavínia Maria Dal’Mas Romera, Gilberto Hideo Kaihami, Grasielle Pereira Jannuzzi et al. · Mycopathologia · 2017 · 10 citations

Life Sciences, Immunology, Microbiology +16